IL6 and lung cancer: Both NFκB-driven and exosomal miR-21a was shown to silence PDCD4, a tumor suppressor and IL-6 inhibitor, promoting the expansion of MDSCs in a IL-6/STAT3 dependant manner in lung cancer (69).